BRIEF-EU medicines agency recommends avoiding some hep C drugs with amiodarone By: Reuters: Company News April 24, 2015 at 07:25 AM EDT * Recommends approval of tasimelteon for non 24-hour sleep-wake disorder from Vanda Pharmaceuticals Read More >> Related Stocks: Bristol-Myers Squibb Vanda Pharmaceuticals